Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
Homology Medicines Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
-
Homology Medicines Reports Second Quarter 2020 Financial Results and Provides Business Update
-
Chardan Capital Markets Starts Homology Medicines (FIXX) at Buy
-
Homology Medicines to Participate in Conferences in October
-
Homology Medicines to Present at Upcoming Conferences
-
Homology Medicines Reports Second Quarter 2018 Financial Results

